21 February 2023
Interview with Dr. Stephanea Sotcheff—Winner of the Pathogens 2022 Best Paper Award
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We recently had the pleasure of speaking with Dr. Stephanea Sotcheff, author of the recently published paper “Understanding Flavivirus Capsid Protein Functions: The Tip of the Iceberg” and winner of the Pathogens 2022 Best Paper Award. In conversation, we discussed the functions of the caps of protein of flaviviruses and how capsid might be used. Dr. Sotcheff is a scholar who carried out her Ph.D. work at the University of Texas Medical Branch, working on flaviviruses and vaccines. She is currently a technical specialist at Thermo Fisher Scientific.
We hope you enjoy the interview.